Literature DB >> 16807651

Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques.

Ann-Trude With Notø1, Ellisiv Bøgeberg Mathiesen, Jean Amiral, Anne Marie Vissac, John-Bjarne Hansen.   

Abstract

Echolucent carotid plaques are associated with high risk for future ischemic cerebrovascular events independent of the degree of stenosis. Elevated levels of markers of systemic inflammation and endothelial dysfunction are predictors for future myocardial infarction and stroke. The present study was undertaken to investigate the relations between plaque morphology, endothelial dysfunction assessed by tissue-plasminogen activator antigen (t-PA ag) and vonWillebrand factor (vWF), and systemic inflammation in persons with carotid stenosis. We conducted a crosssectional study including 133 persons with carotid stenosis and 138 controls without stenosis recruited from the populationbased Tromsø Study. High-resolution B-mode and colour Doppler/pulsed-wave Doppler ultrasonography of both carotid arteries was performed, and plaque morphology in terms of echogenicity was assessed. Persons with carotid stenosis had significantly higher plasma t-PA and vWF concentrations than controls. There was a significant inverse relationship between t-PA ag and plaque echogenicity (p = 0.034). The increased plasma t-PA ag in persons with carotid stenosis was not associated with increased plasminogen activator inhibitor-I (PAI-1). Persons with echolucent carotid plaques had higher degree of systemic inflammation, and plasma t-PA and vWF concentration increased significantly across quartiles of WBC, fibrinogen, and hs-CRP. Our findings may suggest that plasma t-PA may be superior to vWF as a marker for endothelial dysfunction due to its ability to discriminate between various plaque echogenicity, and that the predictive role of t-PA ag in cardiovascular disease is independent of inhibited fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807651     DOI: 10.1160/TH05-11-0772

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Establishment and characterization of an experimental model of coronary thrombotic microembolism in rats.

Authors:  Ye Gu; Yupeng Bai; Jie Wu; Liqun Hu; Bo Gao
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

2.  Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement.

Authors:  Wentao Gong; Xianjun Zhang; Zhen Meng; Feifei Liu; Guangwen Li; Juan Xiao; Peng Liu; Yujie Sun; Tonghui Liu; Hongxia Wang; Yong Zhang; Naidong Wang
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

3.  Efficacy of Shexiang Tongxin Dropping Pills in a Swine Model of Coronary Slow Flow.

Authors:  Yupeng Bai; Mingjing Zhang; Sheng Peng; Yuting Wang; Ye Gu; Qianqian Fang; Liqun Hu
Journal:  Front Physiol       Date:  2022-06-14       Impact factor: 4.755

4.  Brachial artery intima-media thickness and echogenicity in relation to lipids and markers of oxidative stress in elderly subjects:--the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) Study.

Authors:  Lars Lind; Jessika Andersson; Monika Rönn; Thomas Gustavsson; Peter Holdfelt; Johannes Hulthe; Anders Elmgren; Kersti Zilmer; Mihkel Zilmer
Journal:  Lipids       Date:  2007-11-15       Impact factor: 1.880

5.  Association between variations in coagulation system genes and carotid plaque.

Authors:  David Della-Morte; Ashley Beecham; Chuanhui Dong; Liyong Wang; Mark S McClendon; Hannah Gardener; Susan H Blanton; Ralph L Sacco; Tatjana Rundek
Journal:  J Neurol Sci       Date:  2012-09-13       Impact factor: 3.181

6.  Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.

Authors:  Huseyin Oflaz; Ramazan Kurt; Fatma Sen; Imran Onur; Arif Oguzhan Cimen; Ali Elitok; Kultigin Turkmen; Burak Pamukcu; Erdem Kasikcioglu; Zehra Bugra; Fehmi Mercanoglu; Nese Ozbey
Journal:  Endocrine       Date:  2008-01-26       Impact factor: 3.633

7.  Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.

Authors:  Yupeng Bai; Liqun Hu; Jie Wu; Ye Gu; Lun Li; Bo Gao; Hong Jiang
Journal:  Exp Ther Med       Date:  2013-08-16       Impact factor: 2.447

8.  Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.

Authors:  Peter Kraft; Christiane Drechsler; Ignaz Gunreben; Bernhard Nieswandt; Guido Stoll; Peter Ulrich Heuschmann; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.